Sauterzid en es it fr

Sauterzid Brand names, Sauterzid Analogs

Sauterzid Brand Names Mixture

  • No information avaliable

Sauterzid Chemical_Formula


Sauterzid RX_link

Sauterzid fda sheet

Sauterzid FDA

Sauterzid msds (material safety sheet)

Sauterzid MSDS

Sauterzid Synthesis Reference

No information avaliable

Sauterzid Molecular Weight

328.406 g/mol

Sauterzid Melting Point

195-196 oC

Sauterzid H2O Solubility

20 mg/ml (HCl salt)

Sauterzid State


Sauterzid LogP


Sauterzid Dosage Forms

Liquid; Tablet

Sauterzid Indication

For the management of hypertension.

Sauterzid Pharmacology

Labetalol is an alpha-1 and beta adrenergic blocker used to treat high blood pressure. It works by blocking these adrenergic receptors, which slows sinus heart rate, decreases peripheral vascular resistance, and decreases cardiac output.

Sauterzid Absorption

Completely absorbed (100%) from the gastrointestinal tract with peak plasma levels occurring 1 to 2 hours after oral administration. The absolute bioavailability of labetalol is increased when administered with food.

Sauterzid side effects and Toxicity

LD50 = 66 mg/kg (Rat, IV). Side effects or adverse reactions include dizziness when standing up, very low blood pressure, severely slow heartbeat, weakness, diminished sexual function, fatigue

Sauterzid Patient Information

Sauterzid Organisms Affected

Humans and other mammals